Health and Beauty

Glucose Meter Bluetooth

  • What's hot

    Bayer CONTOUR NEXT ONE Bluetooth Glucose Meter [1 pack]
    Health and Beauty (Bayer)


    Bayer


    List Price: $7.50
    Price: $7.00
    You Save: $0.50 (7%)

    • The ONE smart meter and app system to choose for many of your diabetes care needs.
    • Second-Chance technology gives you 60 seconds to reapply blood to the same strip which can help prevent wasted strips
    • Easy as red, yellow, and green with the new smartLIGHT feature
    • Easy to use and most accurate meter yet
    • Immediate results on your Bluetooth-enabled smartphone or tablet

    Contour NEXT ONE Diabetes Testing Kit - 50 Contour NEXT Test Strips, Contour NEXT Control Solution, 50 OWell Lancets, OWell Lancing Device, Manuals & Carry Case
    Health and Beauty (OWell)


    OWell


    List Price: $49.95
    Price: $49.95


    • SATISFACTION GUARANTEED: Includes an extended 18 month product warranted (Exclusively form OTC Outlet).
    • READY TO USE: Straight out of the box. Includes OWell Painless Design Lancets and Lancing Device.
    • FAST & ACCURATE RESULTS: The Contour NEXT Monitoring System requires only a tiny blood sample, is highly accurate, and super easy to use.
    • ALL INCLUSIVE STARTER KIT: This diabetic testing kit includes everything you need to start testing your Blood Glucose Sugar Levels
    • LONG EXPIRATION DATES: All components are fresh with long expiration dates.

iHealth Lab plans to offer iPad glucose meter

iHealth Lab plans to offer iPad glucose meter iHealth Lab announced more than barely the glucose meter: It also unveiled a Bluetooth-enabled version of its Blood Pressure Dock and a new sketch out for its Wireless Body Fat Scale. The company expects to begin shipping each of the three devices during

iHealth Previews iPhone-Connected Blood Glucose Monitor

iHealth Previews iPhone-Connected Blood Glucose Monitor Also displayed at the show were a wireless firmness fat scale that connects to your Apple device via Wi-Fi, and a blood pressure falsify that works with a wireless Bluetooth cuff for more comfortable readings. The blood tension dock also doubles as a

Diabetes: WSJ's Mossberg raves about Telcare's web-friendly glucose monitor

Diabetes: WSJ's Mossberg raves about Telcare's web-friendly glucose monitor Entra Healthfulness Systems sells a Bluetooth-enabled glucose meter, the MyGlucoHealth system, which recently won Canadian approval and has had FDA space and CE Mark approval in the European Union since 2009. Sanofi's (NYSE:SNY) iPhone glucose meter,

Carmakers Count On Tech To Transform Autos Into Companions

A diabetic at the spin could also sync his or her Bluetooth-enabled glucose monitor with the car, which would alert him or her when blood sugar levels collapse. Strumolo additionally described a car that would track elevations in a driver's weight levels

FDA OK's 90-Day Implantable Continuous Glucose Monitor

The small cylindrical device, measuring 3.5 × 18.3 mm, is made of a fluorescence-based glucose sensor implanted subcutaneously under local anesthesia in the patient's upper arm. The glucose data is then transmitted via Bluetooth to the user's mobile application and stored in a HIPAA-compliant cloud. Indicated for use in adults age 18 and older with diabetes -- type 1 or type 2 diabetes -- the CGM is intended to be used in addition to traditional fingerstick blood glucose monitoring.

This approval comes as no surprise, after an FDA advisory committee voted unanimously in March to recommend the device for approval. The panel's backing and the FDA's final approval were largely based upon positive findings from the multicenter PRECISE II trial, which tested the system in 90 patients with type 1 or type 2 diabetes.

Although the device's accuracy during the first 30 days of wear in the trial was questioned during the committee meeting, the overall accuracy of the device throughout the 90-day study was high, with a mean absolute relative difference of 8.5% (95% CI 8.0%-9.1%) from 15,753 unique readings. The device was also able to alert the user to 98% of hyperglycemic events and 96% of hypoglycemic events -- however, 17% and 16% of these were false positives.